drugset / Trial / NCT01701531

Red Blood Cell Precursor Formulation to Determine Increased Production

NCT01701531 ↗

Phase 2/3 Withdrawn Targeted Medical Pharma
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to measure the change in hemoglobin levels after the administration of an amino acid based, RBC precursor formulation.

Timeline

Start
2012-10
Primary completion
2014-05
Completion
2014-05

Outcome

Outcome not reported

Stopped (Business): “Funding not received”

Drugs

EvaluationDrugModalityDoseRoute
Subject RBCPF Other / unclassified — —

Indications